Pasricha P J, Hill S, Wadwa K S, Gislason G T, Okolo P I, Magee C A, Canto M I, Kuo W H, Baust J G, Kalloo A N
Division of Gastroenterology and Hepatology, University of Texas Medical Branch, Galveston, Texas 77555-0764, USA.
Gastrointest Endosc. 1999 May;49(5):627-31. doi: 10.1016/s0016-5107(99)70393-7.
Cryotherapy or the application of extreme cold has many potential applications in gastroenterology including tissue destruction and hemostasis but until now its development has been prevented by the lack of a delivery device suitable for use through the endoscope. We report here our experience with prototype devices using both liquid nitrogen driven by a cryosurgical system and cryogenic refrigerants (nitrous oxide and carbon dioxide) at or near ambient temperature.
Cryotherapy was applied to the distal esophageal mucosa of dogs via a flexible catheter passed through an upper endoscope. In other dogs, cryotherapy was used for hemostasis in a bleeding ulcer model. The procedure was also used for palliation in a 58-year-old man with unresectable adenocarcinoma of the stomach with pyloric channel obstruction.
Freezing of the superficial mucosa was nearly instantaneous. All dogs survived the procedure and appeared to thrive. Histologic evaluation revealed significant necrosis of the superficial epithelial layer accompanied by a fibrinocellular infiltrate on the surface. These markers of acute injury subside by the fourth to sixth day and are replaced by regenerating epithelium, a process that is virtually complete by day 10. In the hemostasis experiments, bleeding ceased immediately after cryospraying of the lesions but resumed on thawing in most cases. Application of cryotherapy in the patient resulted in reduction of the pyloric mass with no immediately apparent adverse effects.
These data, although preliminary, demonstrate the feasibility of endoscopic cryotherapy using a simple hand-held device. This device has broad potential for use in gastroenterology including ablation of superficial epithelium, debulking of large tumors and hemostasis.
冷冻疗法或应用极寒在胃肠病学中有许多潜在应用,包括组织破坏和止血,但迄今为止,其发展因缺乏适合通过内镜使用的输送装置而受阻。我们在此报告我们使用原型设备的经验,该设备使用由冷冻手术系统驱动的液氮以及在环境温度或接近环境温度下的低温制冷剂(一氧化二氮和二氧化碳)。
通过穿过上消化道内镜的柔性导管对犬的食管远端黏膜进行冷冻治疗。在其他犬中,冷冻疗法用于出血性溃疡模型的止血。该方法还用于一名58岁患有无法切除的胃腺癌伴幽门通道梗阻的男性的姑息治疗。
浅表黏膜的冷冻几乎是瞬间完成的。所有犬在手术后存活且似乎茁壮成长。组织学评估显示浅表上皮层有明显坏死,表面伴有纤维细胞浸润。这些急性损伤标志物在第4至6天消退,并被再生上皮取代,该过程在第10天基本完成。在止血实验中,病变冷冻喷雾后出血立即停止,但在大多数情况下解冻后出血恢复。对该患者应用冷冻疗法导致幽门肿块缩小,且无立即明显的不良反应。
这些数据尽管是初步的,但证明了使用简单手持设备进行内镜冷冻疗法的可行性。该设备在胃肠病学中有广泛的应用潜力,包括浅表上皮消融、大肿瘤减瘤和止血。